Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment
EXPLAINER: How will insurers cover a new Alzheimer’s drug?
© The Crystal Eyes